Staffan Lindstrand, Partner, will end the day by telling about the venture capital funds, HealthCap’s business, which was founded in 1996 and invests focused in Life Science. HealthCap has raised more than EUR 1 billion in capital, invested in more than 100 companies, including over 30 IPOs around the world.
The following companies, representing a total market value of approximately SEK 12 billion, will present their business; Aptahem, Bactiguard, Boule Diagnostic, Cellavision, Global Health Partner, Hansa Medical, Karolinska Development, Medcap, Medivir, Midsona, Moberg Pharma, Nanexa, Neurovive, Oasmia Pharmaceutical, Orexo and WntResearch.
For more information contact;
Peter Enström, Chief Executive Officer, tel. 08-440 56 47. peter.enstrom@stockholmcorp.se
